A Comparison of Safety and Outcomes with Cefazolin versus Nafcillin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections

ConclusionCFZ was associated with less nephrotoxicity and no difference in clinical success compared to NAF for MSSA BSI. A prospective study comparing NAF to CFZ for MSSA BSI should be conducted to elucidate differences in therapies.
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research